Skip to main content

Table 1 Main characteristics of the studies included in the systematic review

From: Risk of low bone mineral density in patients with haemophilia: a systematic review and meta-analysis

Study

Year

Country

NO

(H)

NO

(C)

H type

(A/B)

Mean age

(H) (years)

Mean age

(C) (years)

BMI

(H)(kg/m2)

BMI

(C)(kg/m2)

Infected

(HBV/HCV/HIV)

Barnes, C

2004

Australia

19

215

19/0

12.2 ± 3.5

12.8 ± 2.1

N/A

N/A

NA/8/NA

Abdelrazik, N

2007

Egypt

30

30

21/9

4.97 ± 3.64

5.09 ± 3.64

16.76 ± 2.08

17.33 ± 2.19

0/0/0

Nair, A. P

2007

India

50

50

42/8

29.53 ± 9.27

29.20 ± 3.79

19.16 ± 3.8

23.62 ± 2.79

2/18/1

Mansouritorghabeh, H

2008

Iran

18

18

18/0

29.05 ± 8.62

29.05 ± 8.61

22.43 ± 3.30

23.64 ± 3.65

1/11/NA

Tlacuilo-Parra, A

2008

Mexico

62

62

62/0

9.02 ± 3.70

9.30 ± 3.70

18.40 ± 4.50

20.20 ± 5.70

N/A

Mansouritorghabeh, H

2009

Iran

14

14

0/14

30.57 ± 12.18

30.50 ± 12.14

25.37 ± 5.23

25.15 ± 4.89

NA/11/NA

Christoforidis, A

2010

Greece

26

13

26/0

12.08 ± 4.44

11.45 ± 5.26

N/A

N/A

NA/0/0

Rezaeifarid, M

2011

Iran

55

87

N/A

23.5

(Min:16, Max:35)

25.1

(Min:15, Max:35)

N/A

N/A

N/A

Alioglu, B

2012

Turkey

44

40

44/0

160months (Min:36, Max:216)

146months (Min:42, Max:240)

N/A

N/A

N/A

Anagnostis, P

2012

Greece

104

50

90/14

45.87 ± 15.15

44.90 ± 12.80

27.05 ± 4.51

28.49 ± 4.39

4/42/7

Wells, A. J

2015

UK

37

37

37/0

31

(IQR:13–49)

35

(IQR:23–47)

25.4 (IQR:19.7–31.1)

26

(IQR:22.6–30.0)

NA/23/12

Eldash, H. H

2017

Egypt

37

37

N/A

8.3 ± 3.5

7.3 ± 2.2

N/A

N/A

0/0/0

Sossa Melo, C. L

2018

Colombia

90

90

79/11

N/A

N/A

N/A

N/A

N/A

Ashritha, A

2019

India

38

38

35/3

8.7 ± 3.6

8.7 ± 3.5

13.8

(IQR:12.9–15.2)

14.5 (IQR:13.6–15.5)

N/A

Ekinci, O

2019

Turkey

41

40

41/0

26

(Min:18, Max:56)

30

(Min:18, Max:54)

22.7

(Min:15, Max:30)

24.2

(Min:17, Max:32)

3/0/0

El-Mikkawy, D. M. E

2019

Egypt

40

10

40/0

10.98 ± 3.85

10.80 ± 3.49

18.64 ± 3.53

Matched

N/A

Ehsanbakhsh, A

2020

Iran

57

60

57/0

32.9 ± 77.32

34.8 ± 87.40

21.3 ± 49.89

22.4 ± 68.78

N/A

Mohamed, H. R

2020

Egypt

39

20

35/4

9.23 ± 4.36

9.40 ± 4.02

11.79 ± 3.90

12.30 ± 4.13

0/5/0

Patel, G. R

2022

India

39

40

35/4

9.0

(Min:1, Max:17)

9.5

(Min:1, Max:17)

13.8

(Min:10.6, Max:27.7)

14.5

(Min:11.4,

Max:23.2)

0/0/0

  1. H Haemophilia, C Controls, BMI Body mass index, HBV Hepatitis B virus, HCV Hepatitis C virus, HIV Human immunodeficiency virus, N/A Non-available